Advanced search
Start date
Betweenand


Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response

Full text
Author(s):
Londe, Ana Carolina ; Fernandez-Ruiz, Ruth ; Julio, Paulo Rogerio ; Appenzeller, Simone ; Niewold, Timothy B.
Total Authors: 5
Document type: Journal article
Source: JOURNAL OF RHEUMATOLOGY; v. 50, n. 9, p. 11-pg., 2023-09-01.
Abstract

Type I interferon (IFN-I) is thought to play a role in many systemic autoimmune diseases. IFN-I pathway activation is associated with pathogenic features, including the presence of autoantibodies and clinical phenotypes such as more severe disease with increased disease activity and damage. We will review the role and potential drivers of IFN-I dysregulation in 5 prototypic autoimmune diseases: systemic lupus erythematosus, dermatomyositis, rheumatoid arthritis, primary Sjogren syndrome, and systemic sclerosis. We will also discuss current therapeutic strategies that directly or indirectly target the IFN-I system. (AU)

FAPESP's process: 08/02917-0 - Blood and cerebrospinal fluid biomarkers associated with structural and functional central nervous system abnormalities in systemic lupus erythematosus
Grantee:Simone Appenzeller
Support Opportunities: Research Grants - Young Investigators Grants
FAPESP's process: 16/23269-3 - MicroRNAs of TNFa gene in systemic lupus erythematosus: potential biomarkers
Grantee:Mariana Postal Zink de Souza
Support Opportunities: Scholarships in Brazil - Post-Doctoral